Epidemiology and economic burden of nonmelanoma skin cancer

Burak Ömür Cakir; Peter Adamson; Cemal Cingi

doi:10.1016/j.fsc.2012.07.004

Epidemiology and economic burden of nonmelanoma skin cancer

Facial Plast Surg Clin North Am. 2012 Nov;20(4):419-22. doi: 10.1016/j.fsc.2012.07.004.

Authors

Burak Ömür Cakir¹, Peter Adamson, Cemal Cingi

Affiliation

¹ Department of Otorhinolaryngology and Head Neck Surgery, Sisli Etfal Education and Research Hospital, Istanbul, Turkey.

PMID: 23084294
DOI: 10.1016/j.fsc.2012.07.004

Abstract

The authors present a succinct summary of the incidence and costs of nonmelanoma skin cancers. They present incidence and health care costs for this disease from Australia, United States, and Europe, noting that NMSC care cost stands in fifth place after prostate, lung, colon, and breast carcinomas.

Publication types

Review

MeSH terms

Australia / epidemiology
Carcinoma, Basal Cell / economics*
Carcinoma, Basal Cell / epidemiology*
Carcinoma, Squamous Cell / economics*
Carcinoma, Squamous Cell / epidemiology*
Europe / epidemiology
Health Care Costs / statistics & numerical data*
Humans
Incidence
Prevalence
Risk Factors
Skin Neoplasms / economics*
Skin Neoplasms / epidemiology*
United States / epidemiology